• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nanomedicine and macroscale materials in immuno-oncology.纳米医学与免疫肿瘤学中的宏观材料。
Chem Soc Rev. 2019 Jan 2;48(1):351-381. doi: 10.1039/c8cs00473k.
2
Combining Nanomedicine and Immunotherapy.纳米医学与免疫疗法的联合应用。
Acc Chem Res. 2019 Jun 18;52(6):1543-1554. doi: 10.1021/acs.accounts.9b00148. Epub 2019 May 23.
3
Nanomedicine approaches for treatment of hematologic and oncologic malignancies.用于治疗血液学和肿瘤学恶性肿瘤的纳米医学方法。
World J Clin Oncol. 2022 Jul 24;13(7):553-566. doi: 10.5306/wjco.v13.i7.553.
4
Tumor-Targeted Nanomedicine for Immunotherapy.肿瘤靶向纳米医学免疫治疗。
Acc Chem Res. 2020 Dec 15;53(12):2765-2776. doi: 10.1021/acs.accounts.0c00518. Epub 2020 Nov 8.
5
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.通过增强免疫原性细胞死亡来工程化纳米药物,以改善癌症免疫治疗。
Acta Pharmacol Sin. 2020 Jul;41(7):986-994. doi: 10.1038/s41401-020-0400-z. Epub 2020 Apr 21.
6
Nanomedicines modulate the tumor immune microenvironment for cancer therapy.纳米药物通过调节肿瘤免疫微环境来进行癌症治疗。
Expert Opin Drug Deliv. 2024 Dec;21(12):1719-1733. doi: 10.1080/17425247.2024.2412245. Epub 2024 Oct 4.
7
Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy.聚合物纳米药物在癌症免疫治疗中的最新进展。
Adv Healthc Mater. 2019 Feb;8(4):e1801320. doi: 10.1002/adhm.201801320. Epub 2019 Jan 22.
8
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.利用纳米医学提高癌症免疫疗法的疗效:进展、机遇与挑战。
Nat Rev Clin Oncol. 2020 Apr;17(4):251-266. doi: 10.1038/s41571-019-0308-z. Epub 2020 Feb 7.
9
Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy.肿瘤微环境响应型纳米医学用于增强癌症免疫治疗。
Adv Sci (Weinh). 2022 Jan;9(1):e2103836. doi: 10.1002/advs.202103836. Epub 2021 Nov 19.
10
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment.利用纳米医学克服免疫抑制性肿瘤微环境。
Acta Pharmacol Sin. 2020 Jul;41(7):970-985. doi: 10.1038/s41401-020-0424-4. Epub 2020 May 18.

引用本文的文献

1
Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy.纳米材料介导的腺苷途径抑制以增强癌症免疫治疗
Theranostics. 2025 Mar 31;15(11):5007-5028. doi: 10.7150/thno.108931. eCollection 2025.
2
Pan-cancer analysis of DLAT reveals it as a prognostic Biomarker involved in immune infiltration of liver hepatocellular carcinoma.DLAT的泛癌分析表明其作为一种预后生物标志物参与肝细胞癌的免疫浸润。
J Cancer. 2025 Mar 21;16(7):2167-2180. doi: 10.7150/jca.102256. eCollection 2025.
3
Assembly and biological functions of metal-biomolecule network nanoparticles formed by metal-phosphonate coordination.由金属膦酸盐配位形成的金属-生物分子网络纳米颗粒的组装及生物学功能
Sci Adv. 2024 Dec 13;10(50):eads9542. doi: 10.1126/sciadv.ads9542.
4
Personalized cancer vaccines from bacteria-derived outer membrane vesicles with antibody-mediated persistent uptake by dendritic cells.源自细菌外膜囊泡的个性化癌症疫苗,通过抗体介导可被树突状细胞持续摄取。
Fundam Res. 2021 Dec 22;2(1):23-36. doi: 10.1016/j.fmre.2021.11.032. eCollection 2022 Jan.
5
Smart Cancer Nanomedicine for Synergetic Therapy.用于协同治疗的智能癌症纳米药物
Curr Med Chem. 2025;32(2):286-300. doi: 10.2174/0109298673300897240602130258.
6
Role of the gut microbiota in tumorigenesis and treatment.肠道微生物群在肿瘤发生和治疗中的作用。
Theranostics. 2024 Mar 17;14(6):2304-2328. doi: 10.7150/thno.91700. eCollection 2024.
7
Forefronts and hotspots evolution of the nanomaterial application in anti-tumor immunotherapy: a scientometric analysis.纳米材料在抗肿瘤免疫治疗中的应用的前沿和热点演进:一项科学计量学分析。
J Nanobiotechnology. 2024 Jan 13;22(1):30. doi: 10.1186/s12951-023-02278-3.
8
Peptide-Decorated Degradable Polycarbonate Nanogels for Eliciting Antigen-Specific Immune Responses.肽修饰的可降解聚碳酸酯纳米胶束用于诱导抗原特异性免疫反应。
Int J Mol Sci. 2023 Oct 21;24(20):15417. doi: 10.3390/ijms242015417.
9
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.调控骨肉瘤的免疫微环境:骨肉瘤治疗的前景
Bone Res. 2023 Feb 27;11(1):11. doi: 10.1038/s41413-023-00246-z.
10
Artificial and Naturally Derived Phospholipidic Bilayers as Smart Coatings of Solid-State Nanoparticles: Current Works and Perspectives in Cancer Therapy.人工和天然衍生的磷脂双层膜作为固态纳米粒子的智能涂层:癌症治疗中的当前工作和展望。
Int J Mol Sci. 2022 Dec 13;23(24):15815. doi: 10.3390/ijms232415815.

本文引用的文献

1
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.TLR7/8 激动剂负载的纳米颗粒促进肿瘤相关巨噬细胞的极化,以增强癌症免疫治疗。
Nat Biomed Eng. 2018 Aug;2(8):578-588. doi: 10.1038/s41551-018-0236-8. Epub 2018 May 21.
2
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.阿替利珠单抗联合白蛋白紫杉醇治疗晚期三阴性乳腺癌。
N Engl J Med. 2018 Nov 29;379(22):2108-2121. doi: 10.1056/NEJMoa1809615. Epub 2018 Oct 20.
3
Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses.纳米颗粒偶联 TLR7/8 激动剂局部免疫疗法引发安全的抗肿瘤反应。
Adv Mater. 2018 Nov;30(45):e1803397. doi: 10.1002/adma.201803397. Epub 2018 Oct 1.
4
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell.通过转导单个白血病 B 细胞诱导嵌合抗原受体 T 细胞治疗的耐药性。
Nat Med. 2018 Oct;24(10):1499-1503. doi: 10.1038/s41591-018-0201-9. Epub 2018 Oct 1.
5
Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy.用于个性化抗癌免疫治疗的新抗原疫苗递送
Front Immunol. 2018 Jul 2;9:1499. doi: 10.3389/fimmu.2018.01499. eCollection 2018.
6
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery.通过 TCR 信号响应型纳米颗粒药物递送增强 T 细胞疗法。
Nat Biotechnol. 2018 Sep;36(8):707-716. doi: 10.1038/nbt.4181. Epub 2018 Jul 9.
7
Understanding the tumor immune microenvironment (TIME) for effective therapy.理解肿瘤免疫微环境(TIME)以实现有效的治疗。
Nat Med. 2018 May;24(5):541-550. doi: 10.1038/s41591-018-0014-x. Epub 2018 Apr 23.
8
Designing hydrogels for controlled drug delivery.设计用于控释给药的水凝胶。
Nat Rev Mater. 2016 Dec;1(12). doi: 10.1038/natrevmats.2016.71. Epub 2016 Oct 18.
9
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies.免疫检查点阻断联合治疗的新兴概念。
Cancer Cell. 2018 Apr 9;33(4):581-598. doi: 10.1016/j.ccell.2018.03.005.
10
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.巨噬细胞阻碍 CD8 T 细胞到达肿瘤细胞,并限制抗 PD-1 治疗的效果。
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4041-E4050. doi: 10.1073/pnas.1720948115. Epub 2018 Apr 9.

纳米医学与免疫肿瘤学中的宏观材料。

Nanomedicine and macroscale materials in immuno-oncology.

机构信息

Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany.

出版信息

Chem Soc Rev. 2019 Jan 2;48(1):351-381. doi: 10.1039/c8cs00473k.

DOI:10.1039/c8cs00473k
PMID:30465669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7115880/
Abstract

Immunotherapy is revolutionizing the treatment of cancer. It can achieve unprecedented responses in advanced-stage patients, including complete cures and long-term survival. However, immunotherapy also has limitations, such as its relatively low response rates and the development of severe side effects. These drawbacks are gradually being overcome by improving our understanding of the immune system, as well as by establishing combination regimens in which immunotherapy is combined with other treatment modalities. In addition to this, in recent years, progress made in chemistry, nanotechnology and materials science has started to impact immuno-oncology, resulting in more effective and less toxic immunotherapy interventions. In this context, multiple different nanomedicine formulations and macroscale materials have been shown to be able to boost anti-cancer immunity and the efficacy of immunomodulatory drugs. We here review nanotechnological and materials chemistry efforts related to endogenous and exogenous vaccination, to the engineering of antigen-presenting cells and T cells, and to the modulation of the tumor microenvironment. We also discuss limitations, current trends and future directions. Together, the insights provided and the evidence obtained indicate that there is a bright future ahead for engineering nanomedicines and macroscale materials for immuno-oncology applications.

摘要

免疫疗法正在彻底改变癌症的治疗方式。它可以为晚期患者带来前所未有的疗效,包括完全治愈和长期生存。然而,免疫疗法也有其局限性,例如相对较低的反应率和严重副作用的发生。通过加深对免疫系统的了解,并将免疫疗法与其他治疗方法联合使用,这些缺陷正在逐渐得到克服。此外,近年来,化学、纳米技术和材料科学领域的进展开始对免疫肿瘤学产生影响,导致更有效、毒性更小的免疫治疗干预措施。在此背景下,多种不同的纳米药物制剂和宏观材料已被证明能够增强抗癌免疫和免疫调节药物的疗效。在这里,我们综述了与内源性和外源性疫苗接种、抗原呈递细胞和 T 细胞工程以及肿瘤微环境调节相关的纳米技术和材料化学方面的研究进展。我们还讨论了这些研究的局限性、当前的趋势和未来的方向。综上所述,提供的见解和获得的证据表明,为免疫肿瘤学应用工程化纳米药物和宏观材料的未来充满光明。